RVL Pharmaceuticals PLC expected to post a loss of 21  cents a share - Earnings Preview

RVL Pharmaceuticals

09/08/2022 19:34

* RVL Pharmaceuticals PLC  RVLP.OQ   RVLP.O  is expected
to show a
fall in quarterly revenue when it reports  results on August
11. 
    * The Bridgewater New Jersey-based  company is expected to
report 
a 26.0% decrease in revenue to $8.519 million from $11.51
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for RVL Pharmaceuticals
PLC
is for a loss of 21 cents per share. For the same quarter last
year, the company reported a loss of 28 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 18.9%
in the last three months. ​
    * Wall Street's median 12-month price target for RVL
Pharmaceuticals PLC is $4.5​, above​ its last closing price
of $1.59. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.16       -0.17      -0.25     Missed  -45.6
 Dec. 31 2022  -0.25       -0.27      -0.30     Missed  -12.5
 Sep. 30 2021  -0.31       -0.31      -0.28     Beat    11.1​
 Jun. 30 2021  -0.14       -0.14      -0.28     Missed  -100
 ​​Mar.        -0.23       -0.23      -0.15     Beat    36.2
 31 2021                                                
 Dec. 31 2020  -0.28       -0.24      -0.88     Missed  -271.8
                                                        ​
 Sep. 30 2020  -0.20       -0.20      -0.14     Beat    30
 Jun. 30 2020  -0.12       -0.12      -0.22     Missed  -76
 This summary was machine generated August 9 at 18:34 GMT.  All
figures in US dollars  unless otherwise stated